Studies have shown that SphK1 inactivation/silencing could result in ceramide accumulation in cancer cells, which then inactivates Akt-mTOR cascade by activating phosphatases PP2A and PP1 [39, 43, 55, 56]. This evidence concerns the gene SPHK1 and cancer.